79 related articles for article (PubMed ID: 14505301)
1. Changes of insight in manic episodes and influencing factors.
Yen CF; Chen CS; Yeh ML; Yang SJ; Ke JH; Yen JY
Compr Psychiatry; 2003; 44(5):404-8. PubMed ID: 14505301
[TBL] [Abstract][Full Text] [Related]
2. Relationships between insight and medication adherence in outpatients with schizophrenia and bipolar disorder: prospective study.
Yen CF; Chen CS; Ko CH; Yeh ML; Yang SJ; Yen JY; Huang CF; Wu CC
Psychiatry Clin Neurosci; 2005 Aug; 59(4):403-9. PubMed ID: 16048445
[TBL] [Abstract][Full Text] [Related]
3. Relationship between insight and neurocognition in patients with bipolar I disorder in remission.
Yen CF; Cheng CP; Ko CH; Yen JY; Huang CF; Chen CS
Compr Psychiatry; 2008; 49(4):335-9. PubMed ID: 18555052
[TBL] [Abstract][Full Text] [Related]
4. Two cases of bipolar disorder successfully stabilized for five years with a low dose of risperidone and lithium.
Yoshimura R; Ueda N; Shinkai K; Nakamura J
Pharmacopsychiatry; 2006 Nov; 39(6):233-4. PubMed ID: 17124648
[TBL] [Abstract][Full Text] [Related]
5. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.
McIntyre RS; Konarski JZ; Jones M; Paulsson B
J Affect Disord; 2007; 100 Suppl 1():S5-14. PubMed ID: 17391773
[TBL] [Abstract][Full Text] [Related]
6. Changes in insight among patients with bipolar I disorder: a 2-year prospective study.
Yen CF; Chen CS; Ko CH; Yen JY; Huang CF
Bipolar Disord; 2007 May; 9(3):238-42. PubMed ID: 17430298
[TBL] [Abstract][Full Text] [Related]
7. Association between antipsychotic combination therapy and treatment adherence among individuals with bipolar disorder.
Gianfrancesco FD; Sajatovic M; Tafesse E; Wang RH
Ann Clin Psychiatry; 2009; 21(1):3-16. PubMed ID: 19239828
[TBL] [Abstract][Full Text] [Related]
8. The factor structure of clinical symptoms in mixed and manic episodes prior to and after antipsychotic treatment.
Harvey PD; Endicott JM; Loebel AD
Bipolar Disord; 2008 Dec; 10(8):900-6. PubMed ID: 19594505
[TBL] [Abstract][Full Text] [Related]
9. How real are patients in placebo-controlled studies of acute manic episode?
Storosum JG; Fouwels A; Gispen-de Wied CC; Wohlfarth T; van Zwieten BJ; van den Brink W
Eur Neuropsychopharmacol; 2004 Aug; 14(4):319-23. PubMed ID: 15163442
[TBL] [Abstract][Full Text] [Related]
10. The predictive effect of insight on adverse clinical outcomes in bipolar I disorder: a two-year prospective study.
Yen CF; Chen CS; Yen JY; Ko CH
J Affect Disord; 2008 May; 108(1-2):121-7. PubMed ID: 17997489
[TBL] [Abstract][Full Text] [Related]
11. Relationships between insight and psychosocial adjustment in patients with bipolar I disorder.
Yen CF; Chen CS; Yang SJ; Ko CH; Yen JY; Huang CF
Bipolar Disord; 2007 Nov; 9(7):737-42. PubMed ID: 17988364
[TBL] [Abstract][Full Text] [Related]
12. Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study.
Haas M; Delbello MP; Pandina G; Kushner S; Van Hove I; Augustyns I; Quiroz J; Kusumakar V
Bipolar Disord; 2009 Nov; 11(7):687-700. PubMed ID: 19839994
[TBL] [Abstract][Full Text] [Related]
13. Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM).
Vieta E; Angst J; Reed C; Bertsch J; Haro JM;
J Affect Disord; 2009 Nov; 118(1-3):118-23. PubMed ID: 19269690
[TBL] [Abstract][Full Text] [Related]
14. Open-label prospective trial of risperidone in combination with lithium or divalproex sodium in pediatric mania.
Pavuluri MN; Henry DB; Carbray JA; Sampson G; Naylor MW; Janicak PG
J Affect Disord; 2004 Oct; 82 Suppl 1():S103-11. PubMed ID: 15571784
[TBL] [Abstract][Full Text] [Related]
15. Is the polarity of relapse/recurrence in bipolar-I disorder patients related to serum lithium levels? Results from an empirical study.
Severus WE; Kleindienst N; Evoniuk G; Bowden C; Möller HJ; Bohus M; Frangou S; Greil W; Calabrese JR
J Affect Disord; 2009 Jun; 115(3):466-70. PubMed ID: 19019453
[TBL] [Abstract][Full Text] [Related]
16. [Translation and validation of a French version of the Young Mania Rating Scale (YMRS)].
Favre S; Aubry JM; Gex-Fabry M; Ragama-Pardos E; McQuillan A; Bertschy G
Encephale; 2003; 29(6):499-505. PubMed ID: 15029084
[TBL] [Abstract][Full Text] [Related]
17. Quality of life and its association with insight, adverse effects of medication and use of atypical antipsychotics in patients with bipolar disorder and schizophrenia in remission.
Yen CF; Cheng CP; Huang CF; Yen JY; Ko CH; Chen CS
Bipolar Disord; 2008 Jul; 10(5):617-24. PubMed ID: 18657246
[TBL] [Abstract][Full Text] [Related]
18. [Relationships between insight and medication adherence in subjects with psychosis].
Droulout T; Liraud F; Verdoux H
Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
[TBL] [Abstract][Full Text] [Related]
19. Effect of risperidone on plasma catecholamine metabolites and brain-derived neurotrophic factor in patients with bipolar disorders.
Yoshimura R; Nakano Y; Hori H; Ikenouchi A; Ueda N; Nakamura J
Hum Psychopharmacol; 2006 Oct; 21(7):433-8. PubMed ID: 17029305
[TBL] [Abstract][Full Text] [Related]
20. Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study.
Nery FG; Monkul ES; Hatch JP; Fonseca M; Zunta-Soares GB; Frey BN; Bowden CL; Soares JC
Hum Psychopharmacol; 2008 Mar; 23(2):87-94. PubMed ID: 18172906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
